REFERENCES
- Coney, L. R., Tomaselti, A., Carayannopoulas, L., Frasca, V., Kamen, B. A., Colnaught, M. I., and Zurawski, V. R. J. 1991. Cloning of a tumor associated antigen: Moc 18 and Moc 19 antibodies recognize a folate-binding protein. Cancer Res. 51:6125–6132.
- Deflora, A. 1985. The technology of carrier erythrocytes: A versatile tool for diagnosis and therapy. In Biotechnology in Diagnosis, eds. H. Koprowski,
- S. Ferrone, and A. Albertini, 223–236, Plenum press.
- Deloach, J. R. 1983. Encapsulation of exogenous agents in erythrocytes and circulating survival of carrier erythrocytes. J. Appl. Biochem. 5:149–157.
- Jordon, J. A., Alvarez, F. J., Murciano, J. C., Lotero, A., Herraz, A., Tejedor, M. C., Luque, J., Deloach, J. R., and Dlezin, J. C. 1997. Influence of chemical modification on erythrocyte recognition. In Erythrocytes as Drug Carriers in Medicine, eds. Sprandel and Way, 109–112.
- Leamon, C. P., and Low, P. S. 1991. Delivery of macromolecules into living cell: A method that exploits folate receptor endocytosis. Proc. Natl. Acad. Sci. USA 88(113):5572–5576.
- Lejuene, A., Morjani, M., Gicquad, C., Lacroix, J. A., Poyet, P., and Gauderauit, R. C. 1994. Nanoerythrosomes as a new derivative of erythrocyte ghosts: Preparation and antineoplastic potential as drug carrier for daunorubicin. Anticancer Research 14:915–920.
- Mastrobattista, E., Koning, G. A., and Storm, G. 1999. Immunoliposomes for the targeted delivery of antitumor drugs. Adv. Drug Del. Rev. 40: 103–127.
- Mishra, P. R., and Jain, N. K. 2002a. Biotinylated erythrocytes for enhanced liver uptake “A study on the rat.” Int. J. Pharm. 321(2):145–154.
- Mishra, P. R., and Jain, N. K. 2002b. Improved cancer therapy through folate conjugated 6-MP loaded membrane vesicles. Proc. Int. Symp. Control. Rel. Bioact. Mater. Korea:657.
- Mishra, P. R., and Jain, N. K. 2000a. Reverse biomembrane vesicles for effective controlled delivery of Doxorubicin. Drug Del. 7:153–159.
- Mishra, P. R., and Jain, N. K. 2000b. Surface modified methotrexate loaded erythrocytes for enhanced macrophage uptake. J. Drug Targeting 8(4):217– 224.
- Muzykontov, V. R., and Taylor, R. P. 1994. Attachment of biotinylated antibody to red blood cells: Antigen-binding capacity of immunoerythrocytes and their susceptibility to lysis by complement. Anal. Biochem. 223:142–145.
- Penniston, J. T., and Green, D. E. 1968. The conformational basis of energy transformation in membrane system IV energized states and pinocytosis in erythrocyte ghosts. Arch. Biochem. Biophys. 128:339–350.
- Reddy, J. A., and Low, P. S. 1998. Folate-mediated targeting of therapeutic and imaging agents to cancers. Crit. Rev. Ther. Drug Carrier Syst. 15:587– 627
- Rothberg, K. G., Ying, Y. S., Kolghouse, J. F., Kamen, B. A., and Anderson, R. G. 1990. The glycophospholipid-linked folate receptor internalizes fo- late without entering the clathrin coated pit endocytic pathway. J. Cell Biol. 100:637–649.
- Schwoch, G., and Passow, H. 1973. Preparation and properties of human ery- throcyte ghosts. Mol. Cell Biochem. 2(2):197–215.
- Seymour, C. A., Muallen, S., and Law, V. L. 1982. Preparation of inside-out vesicles in one step. In Red Cell Membrane, a Methodological Approach, eds. J. C. Ellory. and J. D. Young, 219–221. London: Academic Press.
- Steck, T. L., Fairbanks, G., and Wallach, D. F. H. 1971. Disposition of the major proteins in the isolated erythrocyte membrane, proteolytic dissection. Biochemistry 10(13):2617–2624.
- Steck, T. L., Straus, J. H., and Wallach, D. F. H. 1970. Inside-out red cell mem- brane vesicle: Preparation and purification. Science 168:255–257.
- Stella, B., Arpicco, S., Peracchia, M. T., Desmaele, D., Hoebeke, J., Renoir, M., D’Angelo, J., Cattel, M., and Couvreur, P. 2000. Design of folic acid- conjugated nanoparticles for drug targeting. J. Pharm. Sci. 89(11):1452– 1464.
- Talwar, N., and Jain, N. K. 1992. Erythrocytes as a carrier for Primaquin: Prepa- ration, characterization and evaluation. J. Control. Rel. 20:133–142.
- Turek, J. J., Leamaon, C. P., and Low, P. S. 1993. Endocytosis of folate pro- tein conjugate, ultrastructural localization in KB cells. Cell Sci. 106(1):423– 430.
- Weitman, S. D., Lark, R. H., Coney, L. R., Fort, D. W., Frasca, V., Zurawski, V. R. J., and Kamen, B. A. 1992. Distribution of the folate receptor GP 38 in normal and malignant tissues. Cancer Res. 52(12)3396–3401.